Spectrum Pharmaceuticals Inc posts annual revenue of $10.11 million in 2022

Spectrum Pharmaceuticals Inc [SPPI] has reported $75.40 million loss for the fiscal year ending Dec 31, 2022.

Revenue for the year was $10.11 million with operating income of $78.10 million.

The Irvine, Nevada (NV)-based company operating in the pharmaceutical preparations sector with 86 employees has total shareholders equity of $27.89 million.

Also read:

This is a developing story. Click here to receive updates.

------------

NewsInMinutes, an offering of 10kInfo, Inc., brings you news on the latest regulatory filings. Subscribe to additional news alerts here.